Study suggests mammograms under 50 if family risk

November 18, 2010 By MARIA CHENG , AP Medical Writer

(AP) -- Women in their 40s with a moderate family risk of breast cancer should get yearly mammograms, a new study suggests.

Though such testing is standard procedure in the U.S., women in Europe who have an intermediate family risk are not always offered screening if they are under 50.

British researchers followed 6,710 women under 50 who had a moderate breast cancer risk - meaning women who meet criteria such as having one close female relative who had breast cancer in her 40s or younger. Such woman have double to triple the risk of having breast cancer as the average woman.

The women were monitored for about five years and given a yearly mammogram for about four years. A total of 136 women from the group were diagnosed with breast cancer during the course of the study.

Doctors thought it would be unethical to have a comparison group that was not offered screening. So they used two previous studies: of women who were not screened and of breast cancer patients with a family history.

The study was too short to show whether the screening saved lives, but using tumor size and severity, Duffy and colleagues estimated annual reduced the death rate by 20 percent in women with a moderate family breast cancer risk.

The tumors they found were also smaller and less likely to have spread when compared to women who hadn't been screened and later had cancer. The scientists calculated two women would be saved for every 1,000 women screened over a decade.

The research was published online Thursday in the medical journal Lancet Oncology. It was paid for by the U.K. National Health Service Technology Assessment.

In Britain and elsewhere in Europe, women can get mammograms every two years from age 50 to 70 unless they have a high risk of breast cancer, in which case they may be tested earlier.

"At the moment, whether or not women with a moderate family risk get tested varies considerably," said Stephen Duffy, professor of at Queen Mary University of London and one of the study authors.

"We hope our findings will push governments to make this kind of mammography universal for these women."

Policies and opinions vary on whether women at average risk should be screened before 50. A U.S. health task force last year concluded that women at average risk for breast cancer don't need mammograms in their 40s but not all groups agreed with that decision.

"All women over 40, both those at normal risk and intermediate and high risk, should be getting mammograms on a regular basis," said Otis Brawley, chief medical officer of the American Cancer Society. He was not linked to the study.

Karsten Jorgensen of the Nordic Cochrane Centre in Copenhagen said doctors are overtreating and many women who are screened will test positive for a cancer that would never have threatened their health.

"Any woman needs to consider the harms and benefits carefully before she decides if she wants to be screened," he said.

More information: http://www.lancet.com

shares

Related Stories

Recommended for you

Many pelvic tumors in women may have common origin—fallopian tubes

October 17, 2017
Most—and possibly all—ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.

New bowel cancer drug target discovered

October 17, 2017
Researchers at the Francis Crick Institute have discovered a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies.

Researchers find novel mechanism of resistance to anti-cancer drugs

October 17, 2017
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However, many patients have tumors ...

Using artificial intelligence to improve early breast cancer detection

October 17, 2017
Every year 40,000 women die from breast cancer in the U.S. alone. When cancers are found early, they can often be cured. Mammograms are the best test available, but they're still imperfect and often result in false positive ...

New assay may boost targeted treatment of non-Hodgkin lymphoma

October 17, 2017
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment ...

Biology of childhood brain tumor subtypes offers clues to precision treatments

October 17, 2017
Researchers investigating pediatric low-grade gliomas (PLGG), the most common type of brain tumor in children, have discovered key biological differences in how mutated genes combine with other genes to drive this childhood ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.